Senti Biosciences Holdings, Inc. SEC filings SNTI
Senti Biosciences Holdings, Inc. has 367 filings in SEC EDGAR's recent list, going back to Apr 2, 2021. Its latest annual report, Form ARS, was filed on Jul 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Sep 24, 2026 | — |
| S-3/A | Filing | Sep 22, 2026 | — |
| S-3/A | Filing | Sep 10, 2026 | — |
| S-3/A | Filing | Jul 16, 2026 | — |
| S-3 | Shelf registration | Jun 18, 2026 | — |
| 424B5 | Prospectus supplement | May 1, 2026 | — |
| S-8 | Employee stock plan registration | Apr 24, 2026 | — |
| S-8 POS | Filing | Apr 24, 2026 | — |
| S-8 POS | Filing | Apr 24, 2026 | — |
| S-8 POS | Filing | Apr 24, 2026 | — |
| S-8 POS | Filing | Apr 24, 2026 | — |
| POS AM | Filing | Apr 24, 2026 | — |
| POS AM | Filing | Apr 24, 2026 | — |
| POS AM | Filing | Apr 24, 2026 | — |
| POS AM | Filing | Apr 24, 2026 | — |
| 424B5 | Prospectus supplement | Mar 31, 2025 | — |
| S-3 | Shelf registration | Mar 21, 2025 | — |
| S-3 | Shelf registration | Mar 21, 2025 | — |
| S-8 | Employee stock plan registration | Mar 7, 2025 | — |
| S-8 | Employee stock plan registration | Jan 10, 2024 | — |
| 424B3 | Prospectus | Nov 13, 2023 | — |
| 424B3 | Prospectus | Nov 13, 2023 | — |
| POS AM | Filing | Nov 1, 2023 | — |
| POS AM | Filing | Nov 1, 2023 | — |
| 424B3 | Prospectus | Aug 11, 2023 | — |
| 424B3 | Prospectus | Aug 11, 2023 | — |
| 424B3 | Prospectus | Aug 11, 2023 | — |
| 424B3 | Prospectus | Aug 11, 2023 | — |
| 424B3 | Prospectus | Aug 10, 2023 | — |
| 424B3 | Prospectus | Aug 10, 2023 | — |
| 424B3 | Prospectus | Jun 23, 2023 | — |
| 424B3 | Prospectus | Jun 23, 2023 | — |
| 424B3 | Prospectus | May 9, 2023 | — |
| 424B3 | Prospectus | May 9, 2023 | — |
| 424B3 | Prospectus | Apr 28, 2023 | — |
| 424B3 | Prospectus | Apr 28, 2023 | — |
| 424B3 | Prospectus | Mar 23, 2023 | — |
| 424B3 | Prospectus | Mar 23, 2023 | — |
| S-8 | Employee stock plan registration | Feb 16, 2023 | — |
| 424B3 | Prospectus | Jan 27, 2023 | — |
| 424B3 | Prospectus | Jan 27, 2023 | — |
| 424B3 | Prospectus | Dec 12, 2022 | — |
| 424B3 | Prospectus | Dec 12, 2022 | — |
| 424B3 | Prospectus | Nov 14, 2022 | — |
| 424B3 | Prospectus | Nov 10, 2022 | — |
| 424B3 | Prospectus | Sep 30, 2022 | — |
| S-1 | Registration statement | Sep 12, 2022 | — |
| 424B3 | Prospectus | Sep 1, 2022 | — |
| S-8 | Employee stock plan registration | Aug 18, 2022 | — |
| 424B3 | Prospectus | Aug 15, 2022 | — |
| 424B3 | Prospectus | Aug 9, 2022 | — |
| S-1/A | Amended registration statement | Jul 29, 2022 | — |
| S-1 | Registration statement | Jun 28, 2022 | — |
| 424B3 | Prospectus | May 13, 2022 | — |
| S-4/A | Filing | May 10, 2022 | — |
| S-4/A | Filing | Apr 22, 2022 | — |
| S-4/A | Filing | Apr 1, 2022 | — |
| S-4 | Registration for a merger or exchange | Feb 14, 2022 | — |
| 424B5 | Prospectus supplement | May 27, 2021 | — |
| S-1/A | Amended registration statement | May 24, 2021 | — |
| S-1/A | Amended registration statement | May 21, 2021 | — |
| S-1 | Registration statement | May 7, 2021 | — |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SNTI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1854270
- Former names
- Senti Biosciences, Inc. (until May 8, 2026); Senti Biosciences, Inc.\ (until Jun 28, 2022); Dynamics Special Purpose Corp. (until Jun 13, 2022)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.